• Aucun résultat trouvé

MODULE FOR ASSESSING AND STRENGTHENING THE QUALITY OF VIRAL LOAD TESTING DATA WITHIN HIV PROGRAMMES AND PATIENT MONITORING SYSTEMS

N/A
N/A
Protected

Academic year: 2022

Partager "MODULE FOR ASSESSING AND STRENGTHENING THE QUALITY OF VIRAL LOAD TESTING DATA WITHIN HIV PROGRAMMES AND PATIENT MONITORING SYSTEMS"

Copied!
4
0
0

Texte intégral

(1)

HIV STRATEGIC INFORMATION FOR IMPACT

SEPTEMBER 2020

MODULE FOR ASSESSING AND STRENGTHENING THE QUALITY OF VIRAL LOAD TESTING DATA WITHIN HIV PROGRAMMES AND PATIENT MONITORING SYSTEMS

WEB ANNEX B: MAP OF PATIENT, VIRAL LOAD SAMPLE AND DOCUMENTATION FLOW

IMPLEMENT ATION TOOL

(2)

Web Annex B: Map of patient, viral load sample and documentation flow

1

In tr oduc tor y s cr ip t f or d at a a nd s er vic e m ap pi ng Th ank y ou f or h av in g us a t y ou r f ac ili ty t od ay . W e w ou ld l ik e t o lo ca te an d fi x an y da ta d ef ec ts o r b ot tle ne ck s w ith in t he d at a w or kfl ow t o i m pr ov e t he q ua lit y o f in fo rm at io n g at he re d i n r ea l t im e an d m ov in g f or w ar d. W e w ou ld l ik e t o h el p t o st reng th en a nd s tre am lin e t he p ro ce ss for v al id at ing pa tie nt h ea lth in for m at ion . To da y, w e ar e i nt er es te d i n le ar ni ng a bo ut t he d at a an d s er vi ce q ua lit y c ha lle ng es an d s uc ce ss es a t y ou r s ite . T he se g ui di ng q ue st io ns an d t he s ite v is it w ill b e an op po rt un ity t o d el ve d ee p i nt o t he c ha lle ng es , s uc ce ss es , b es t p rac tic es an d in no va tio n i n t he h ea lth i nf or m at io n s ys te m s h er e a t y ou r f ac ili ty . T o b eg in , w e w ou ld li ke y ou t o w al k u s t hr ou gh t he p ro ce ss o f o rd er in g a v ir al l oa d te st f or a p at ie nt . W he re d oe s t he p at ie nt g o f or s am pl e c ol le ct io n, w ha t ha pp en s i f a p at ie nt d oe s n ot g et a s am pl e d ra w n? W ha t h ap pe ns w he n vi ra l l oa d te st r es ul ts a re n ot r ec ei ve d? I s t he re a m ec ha ni sm t o f ol lo w u p w it h t he l ab or at or y o n te st s t ha t h av e o rd er ed b ut n o r es ul ts r ec ei ve d? A re t he re a ny b ot tl en ec ks i n t he p ro ce ss a nd , i f s o, w he re a re t he y? In st ru ct io n: s ke tc h a m ap o f s er vi ce d el iv er y fl ow b as ed o n t he r es po ns es t o t he qu es tio ns h ig hl ig ht ed a bo ve .

N am e o f i nt er vie w ee Fa cili ty c od e

WEB ANNEX B MAP OF PATIENT, VIRAL LOAD SAMPLE AND DOCUMENTATION FLOW

IN ST RU CT IO NS : S KE TC H A R OU GH M AP A ND M AK E N OT ES O F S PE CI FIC B ES T P RA CT IC ES O R P OT EN TI AL I M PR OV EM EN TS F OR E FF IC IE NC Y I N D AT A F LO W

Guiding questions Sketch flow • Is viral load testing performed routinely or targeted at specific populations? • Are any prompts or tools used to remind service providers to order a viral load test for eligible patients? • What tools are used to order a viral load test and who completes them? • How often are viral load samples picked up for transport to the laboratory? Is the schedule for pick-up followed? Reasons for deviations? • How are results transmitted from the lab to the antiretroviral therapy clinic? • What tools are used to record viral load test results • Are any tools used to support the follow-up of patients with elevated viral load? • How are the returned results entered into patient files and by whom? • How are viral load results provided to patients? • What is the process of updating registers after patient visits? • Who enters the data in registers or electronic medical records (if relevant) • Are any tools used to monitor sample collection kits and blood draw–related commodities?

N am e o f fa ci lit y

(3)

Web Annex B: Map of patient, viral load sample and documentation flow

2

List any best practices in viral load patient, sample and documentation flow 1. 2. Provide any comments or recommendations to improve efficiencies in patient, sample and documentation flow 1. 2. List 3–5 critical challenges impacting viral load monitoring and scale-up in your facility 1. 2. 3. 4. 5. Provide any comments, best practices or recommendations for strengthening viral load monitoring and scale-up that could be applicable to other settings 1. 2. 3. 4. 5.

(4)

For more information, contact:

World Health Organization Department of HIV/AIDS 20, avenue Appia 1211 Geneva 27 Switzerland

E-mail: [email protected] www.who.int/hiv

ISBN 978-92-4-001040-6 (electronic version)

© World Health Organization 2020. Some rights reserved.

This work is available under the CC BY-NC-SA 3.0 IGO licence.

Références

Documents relatifs

Plasma is therefore the preferred sample type for viral load testing; however, alternative specimen types and technologies exist to support expanded access to viral load

Revising and updating national guidelines on ART and monitoring for HIV infection and developing national policies and plans for implementing viral load testing are essential